Henry Mayer Center, Hospital Clínico Universidad de Chile
Santiago, Santiago Metropolitan, Chile
NCT Number: NCT00273065
The purpose of this study is to evaluate the local anesthetic properties of neosaxitoxin in humans
Looking for future studies?
Notify Me18 year–50 year
Male
Interventional
Phase 1
Santiago, Santiago Metropolitan, Chile
Neosaxitoxin is a phycotoxins that reversible block the voltage-gated sodium channels at neuronal level. Its activity is express as blocking the axonal conduction, stopping the propagation of the nerve impulse. The objective of the present work is to evaluate the neosaxitoxin efficacy and safety as local anesthetic in a human trial
Methods: Randomized, double-blind, placebo-controlled trial, with 10 healthy volunteers. The anesthetic effect will be evaluated using a standardized human sensory and pain model. TSA Neurosensory analyser and Von Frey Technique will be used to evaluate five parameters: sensory threshold for warm and cold, pain thresholds for heat and cold and mechanical touch perception threshold.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University of Chile
Other
Phase 1 Study of Local Infiltration of Neosaxitoxin as a Local Anesthetic
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02956512
Healthy Volunteers
Valinhos, São Paulo, Brazil
View Trial DetailsNCT00001309
Healthy Volunteers
Bethesda, Maryland, United States
View Trial DetailsNCT00001471
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Bethesda, Maryland, United States
View Trial DetailsNCT01517100
Glucose Metabolism Disorders, Healthy Volunteers
Baltimore, Maryland, United States
View Trial Details